SK279913B6 - Farmaceutický prostriedok vo forme krému - Google Patents

Farmaceutický prostriedok vo forme krému Download PDF

Info

Publication number
SK279913B6
SK279913B6 SK592-95A SK59295A SK279913B6 SK 279913 B6 SK279913 B6 SK 279913B6 SK 59295 A SK59295 A SK 59295A SK 279913 B6 SK279913 B6 SK 279913B6
Authority
SK
Slovakia
Prior art keywords
weight
cream
parts
dihydroxycholecalciferol
component
Prior art date
Application number
SK592-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK59295A3 (en
Inventor
Yuji Makino
Hideo Matugi
Yoshiki Suzuki
Original Assignee
Teijin Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Limited filed Critical Teijin Limited
Publication of SK59295A3 publication Critical patent/SK59295A3/sk
Publication of SK279913B6 publication Critical patent/SK279913B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
SK592-95A 1993-09-01 1994-09-01 Farmaceutický prostriedok vo forme krému SK279913B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21726193 1993-09-01
PCT/JP1994/001443 WO1995006482A1 (fr) 1993-09-01 1994-09-01 COMPOSITION D'EMULSION A BASE DE 1α,24-(OH)2-VITAMINE D¿3?

Publications (2)

Publication Number Publication Date
SK59295A3 SK59295A3 (en) 1995-12-06
SK279913B6 true SK279913B6 (sk) 1999-05-07

Family

ID=16701374

Family Applications (1)

Application Number Title Priority Date Filing Date
SK592-95A SK279913B6 (sk) 1993-09-01 1994-09-01 Farmaceutický prostriedok vo forme krému

Country Status (17)

Country Link
US (1) US5612327A (de)
EP (1) EP0667166B1 (de)
JP (1) JP3045179B2 (de)
KR (1) KR100221045B1 (de)
CN (1) CN1082818C (de)
AT (1) ATE195431T1 (de)
CA (1) CA2148109C (de)
CZ (1) CZ284261B6 (de)
DE (1) DE69425552T2 (de)
DK (1) DK0667166T3 (de)
ES (1) ES2148340T3 (de)
NO (1) NO312227B1 (de)
PL (1) PL175492B1 (de)
PT (1) PT667166E (de)
SG (1) SG52313A1 (de)
SK (1) SK279913B6 (de)
WO (1) WO1995006482A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
KR100387156B1 (ko) 1995-04-21 2003-10-11 세키스이가가쿠 고교가부시키가이샤 피부질환치료용외용제
DE19639816A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US20040039030A1 (en) * 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
ES2245511T3 (es) 1998-03-04 2006-01-01 Teijin Limited Lociones de vitamina d3 activa en forma de emulsion.
AU762481C (en) * 1998-03-27 2004-08-19 Oregon Health Sciences University Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
IL153378A0 (en) * 2000-07-18 2003-07-06 Bone Care Internat Inc STABILIZED 1alpha-HYDROXY VITAMIN D
US20030191093A1 (en) * 2001-12-03 2003-10-09 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US20060189586A1 (en) * 2003-06-11 2006-08-24 Cleland Jeffrey L Pharmaceutical compositions comprising active vitamin D compounds
US20050020546A1 (en) * 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
ES2407407T3 (es) 2005-06-01 2013-06-12 Glaxosmithkline Intellectual Property Development Limited Formulación de vitamina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
JPS6226223A (ja) * 1985-07-25 1987-02-04 Teijin Ltd 乾癬治療剤
JPH0774144B2 (ja) * 1986-03-12 1995-08-09 久光製薬株式会社 尿素を含有する皮膚用組成物
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment

Also Published As

Publication number Publication date
CA2148109C (en) 1999-11-23
DK0667166T3 (da) 2000-10-16
SK59295A3 (en) 1995-12-06
DE69425552D1 (de) 2000-09-21
CN1114824A (zh) 1996-01-10
JP3045179B2 (ja) 2000-05-29
CA2148109A1 (en) 1995-03-09
KR950703998A (ko) 1995-11-17
PT667166E (pt) 2001-02-28
EP0667166A1 (de) 1995-08-16
CN1082818C (zh) 2002-04-17
PL308748A1 (en) 1995-08-21
NO951639L (no) 1995-06-30
ATE195431T1 (de) 2000-09-15
CZ113295A3 (en) 1995-11-15
KR100221045B1 (ko) 1999-09-15
WO1995006482A1 (fr) 1995-03-09
DE69425552T2 (de) 2001-04-19
CZ284261B6 (cs) 1998-10-14
EP0667166B1 (de) 2000-08-16
NO312227B1 (no) 2002-04-15
EP0667166A4 (de) 1995-11-02
ES2148340T3 (es) 2000-10-16
US5612327A (en) 1997-03-18
SG52313A1 (en) 1998-09-28
NO951639D0 (no) 1995-04-28
PL175492B1 (pl) 1999-01-29

Similar Documents

Publication Publication Date Title
SK279913B6 (sk) Farmaceutický prostriedok vo forme krému
EP0979654B1 (de) Aktives vitamin-d3 enthaltende lotionen in form von emulsionen
CA1192496A (en) Topical pharmaceutical compositions
EP0981330B1 (de) Topische mittel
US4794106A (en) Cream
EP0124147B1 (de) Mittel zur Aknebehandlung Spironolakton enthaltend
EP0097374A2 (de) Topische Corticosteroid-Präparate
CA2312731A1 (en) Creams containing vitamin d3 derivatives
HUE027718T2 (en) Oil-in-water emulsion containing mometasone and propylene glycol
US20230390196A1 (en) Emulsion composition for external use
HU218585B (hu) 1-alfa,24-(OH)2-V.D3-at tartalmazó emulzió psoriasis kezelésére
HUE030827T2 (en) Mometasone oil-in-water emulsion
CA2156396A1 (en) Stable dermatologic preparation containing mycophenolic acid

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20140901